EVOFEM BIOSCIENCES, INC.
Profile
Company Names
EVOFEM BIOSCIENCES, INC.
Addresses
7770 REGENTS ROAD, SUITE 113-6188, SAN DIEGO, CA 92122
7770 REGENTS ROAD, SUITE 113-618, SAN DIEGO, CA 92122
7770 REGENTS ROAD, SUITE 113-618, SAN DIEGO, CA 92122
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA 92130
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA 92130
Phone Numbers
(858) 550-1900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$85,551,925.00
Number of Funding Rounds:
11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2025-06-26
$925,000.00
$925,000.00
$0.00
Equity
10
2025-04-08
$750,000.00
$1,500,000.00
$750,000.00
Equity
9
2024-08-09
$500,000.00
$500,000.00
$0.00
Equity
8
2024-07-12
$500,000.00
$500,000.00
$0.00
Equity
7
2023-09-27
$2,884,615.00
$2,884,615.00
$0.00
Debt
6
2023-02-17
$1,384,616.00
$1,384,616.00
$0.00
Debt
5
2022-12-20
$2,307,693.00
$2,307,693.00
$0.00
Equity, Debt
4
2020-10-14
$25,000,000.00
$25,000,000.00
$0.00
Debt
3
2020-04-24
$15,000,000.00
$25,000,000.00
$10,000,000.00
Debt
2
2019-04-11
$30,000,001.00
$80,000,000.00
$49,999,999.00
Equity
1
2019-02-08
$6,300,000.00
$12,500,000.00
$6,200,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KELLY
CULWELL
EXECUTIVE OFFICER
WILLIAM
HALL
DIRECTOR
KIM
KAMDAR
DIRECTOR
THOMAS
LYNCH
DIRECTOR
PROFECTUS BIOSCIENCES INC
| XOS TECHNOLOGIES INC
| EVOFEM HOLDINGS, INC.
| OREXIGEN THERAPEUTICS, INC.
| MRMMK HOLD CO.
| IPI DATA CENTER PARTNERS FUND I-A, L.P.
| IPI DATA CENTER PARTNERS FUND I-B, L.P.
| EVOFEM BIOSCIENCES, INC.
| EVOFEM BIOSCIENCES, INC.
| FUSION RECRUITING LABS, INC.
| IPI PARTNERS II-A, L.P.
| IPI PARTNERS II-B, L.P.
| IPI PARTNERS II-D, L.P.
| STACK INFRASTRUCTURE USA II, LLC
| STACK PARCEL HOLDINGS, LLC
| BAINBRIDGE HEALTH, INC.
| IPI PARTNERS III-B, L.P.
| IPI PARTNERS III-A, L.P.
| QVIDTVM INC.
| STACK NVA HOLDINGS REIT, LLC
| AQ SUNSHINE PARENT, LLC
SAUNDRA
PELLETIER
EXECUTIVE OFFICER, DIRECTOR
COLIN
RUTHERFORD
DIRECTOR
JENNY
YIP
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-06-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-04-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-07-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-08-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-09-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-02-17
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2022-12-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-10-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-04-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-04-11
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-02-08

